The global In - Vitro ADME Services market size was valued at US$ 980 million in 2024 and is forecast to a readjusted size of USD 1715 million by 2031 with a CAGR of 8.2% during review period.
In-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) services are a set of techniques used in drug development to assess the pharmacokinetic properties of a compound before it is tested in animals or humans. These services involve the use of in-vitro assays to measure how a compound is absorbed, distributed, metabolized, and eliminated by the body. In-vitro ADME services can provide critical information about a compound's potential efficacy and safety profile, and can help identify potential issues early in the drug development process.
The core manufacturers of global in-vitro ADME services include Charles River, Labcorp, Envigo, Curia, Evotec and Bioduro-Sundia. The top five manufacturers account for approximately 39% of the global share. Charles River is the world's largest in-vitro ADME services provider, with a market share of approximately 16%.
The United States is the world's largest in-vitro ADME services market, accounting for nearly 48% of the market share. The second and third places are Europe and Asia-Pacific, accounting for 29% and 20% respectively.
In terms of product types, small molecule occupies a dominant position, accounting for 75% of the market share. At the same time, in terms of end users, biopharmaceutical companies are the largest end users, accounting for 84%.
This report is a detailed and comprehensive analysis for global In - Vitro ADME Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global In - Vitro ADME Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global In - Vitro ADME Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global In - Vitro ADME Services market size and forecasts, by Type and by End User, in consumption value ($ Million), 2020-2031
Global In - Vitro ADME Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In - Vitro ADME Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In - Vitro ADME Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Labcorp, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec, IQVIA, Tecan Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
In - Vitro ADME Services market is split by Type and by End User. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Small Molecules
Biologics
麻豆原创 segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
麻豆原创 segment by players, this report covers
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In - Vitro ADME Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In - Vitro ADME Services, with revenue, gross margin, and global market share of In - Vitro ADME Services from 2020 to 2025.
Chapter 3, the In - Vitro ADME Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by End User, with consumption value and growth rate by Type, by End User, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and In - Vitro ADME Services market forecast, by regions, by Type and by End User, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of In - Vitro ADME Services.
Chapter 13, to describe In - Vitro ADME Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of In - Vitro ADME Services by Type
1.3.1 Overview: Global In - Vitro ADME Services 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global In - Vitro ADME Services Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Small Molecules
1.3.4 Biologics
1.4 Global In - Vitro ADME Services 麻豆原创 by End User
1.4.1 Overview: Global In - Vitro ADME Services 麻豆原创 Size by End User: 2020 Versus 2024 Versus 2031
1.4.2 Biopharmaceutical Companies
1.4.3 Government and Academic Institutes
1.4.4 Others
1.5 Global In - Vitro ADME Services 麻豆原创 Size & Forecast
1.6 Global In - Vitro ADME Services 麻豆原创 Size and Forecast by Region
1.6.1 Global In - Vitro ADME Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global In - Vitro ADME Services 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America In - Vitro ADME Services 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe In - Vitro ADME Services 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific In - Vitro ADME Services 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America In - Vitro ADME Services 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa In - Vitro ADME Services 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River In - Vitro ADME Services Product and Solutions
2.1.4 Charles River In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Labcorp
2.2.1 Labcorp Details
2.2.2 Labcorp Major Business
2.2.3 Labcorp In - Vitro ADME Services Product and Solutions
2.2.4 Labcorp In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Labcorp Recent Developments and Future Plans
2.3 Envigo
2.3.1 Envigo Details
2.3.2 Envigo Major Business
2.3.3 Envigo In - Vitro ADME Services Product and Solutions
2.3.4 Envigo In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Envigo Recent Developments and Future Plans
2.4 Curia
2.4.1 Curia Details
2.4.2 Curia Major Business
2.4.3 Curia In - Vitro ADME Services Product and Solutions
2.4.4 Curia In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Curia Recent Developments and Future Plans
2.5 Evotec
2.5.1 Evotec Details
2.5.2 Evotec Major Business
2.5.3 Evotec In - Vitro ADME Services Product and Solutions
2.5.4 Evotec In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Evotec Recent Developments and Future Plans
2.6 Bioduro-Sundia
2.6.1 Bioduro-Sundia Details
2.6.2 Bioduro-Sundia Major Business
2.6.3 Bioduro-Sundia In - Vitro ADME Services Product and Solutions
2.6.4 Bioduro-Sundia In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Bioduro-Sundia Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza In - Vitro ADME Services Product and Solutions
2.7.4 Lonza In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Lonza Recent Developments and Future Plans
2.8 WuXi AppTec
2.8.1 WuXi AppTec Details
2.8.2 WuXi AppTec Major Business
2.8.3 WuXi AppTec In - Vitro ADME Services Product and Solutions
2.8.4 WuXi AppTec In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 WuXi AppTec Recent Developments and Future Plans
2.9 IQVIA
2.9.1 IQVIA Details
2.9.2 IQVIA Major Business
2.9.3 IQVIA In - Vitro ADME Services Product and Solutions
2.9.4 IQVIA In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 IQVIA Recent Developments and Future Plans
2.10 Tecan Group
2.10.1 Tecan Group Details
2.10.2 Tecan Group Major Business
2.10.3 Tecan Group In - Vitro ADME Services Product and Solutions
2.10.4 Tecan Group In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Tecan Group Recent Developments and Future Plans
2.11 Pharmaron
2.11.1 Pharmaron Details
2.11.2 Pharmaron Major Business
2.11.3 Pharmaron In - Vitro ADME Services Product and Solutions
2.11.4 Pharmaron In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Pharmaron Recent Developments and Future Plans
2.12 Shanghai Medicilon
2.12.1 Shanghai Medicilon Details
2.12.2 Shanghai Medicilon Major Business
2.12.3 Shanghai Medicilon In - Vitro ADME Services Product and Solutions
2.12.4 Shanghai Medicilon In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Shanghai Medicilon Recent Developments and Future Plans
2.13 ChemPartner
2.13.1 ChemPartner Details
2.13.2 ChemPartner Major Business
2.13.3 ChemPartner In - Vitro ADME Services Product and Solutions
2.13.4 ChemPartner In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 ChemPartner Recent Developments and Future Plans
2.14 Joinn Laboratories
2.14.1 Joinn Laboratories Details
2.14.2 Joinn Laboratories Major Business
2.14.3 Joinn Laboratories In - Vitro ADME Services Product and Solutions
2.14.4 Joinn Laboratories In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Joinn Laboratories Recent Developments and Future Plans
2.15 RTI International
2.15.1 RTI International Details
2.15.2 RTI International Major Business
2.15.3 RTI International In - Vitro ADME Services Product and Solutions
2.15.4 RTI International In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 RTI International Recent Developments and Future Plans
2.16 Eurofins Scientific
2.16.1 Eurofins Scientific Details
2.16.2 Eurofins Scientific Major Business
2.16.3 Eurofins Scientific In - Vitro ADME Services Product and Solutions
2.16.4 Eurofins Scientific In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Eurofins Scientific Recent Developments and Future Plans
2.17 Aragen Life Sciences
2.17.1 Aragen Life Sciences Details
2.17.2 Aragen Life Sciences Major Business
2.17.3 Aragen Life Sciences In - Vitro ADME Services Product and Solutions
2.17.4 Aragen Life Sciences In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Aragen Life Sciences Recent Developments and Future Plans
2.18 Sai Life Sciences
2.18.1 Sai Life Sciences Details
2.18.2 Sai Life Sciences Major Business
2.18.3 Sai Life Sciences In - Vitro ADME Services Product and Solutions
2.18.4 Sai Life Sciences In - Vitro ADME Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Sai Life Sciences Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global In - Vitro ADME Services Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of In - Vitro ADME Services by Company Revenue
3.2.2 Top 3 In - Vitro ADME Services Players 麻豆原创 Share in 2024
3.2.3 Top 6 In - Vitro ADME Services Players 麻豆原创 Share in 2024
3.3 In - Vitro ADME Services 麻豆原创: Overall Company Footprint Analysis
3.3.1 In - Vitro ADME Services 麻豆原创: Region Footprint
3.3.2 In - Vitro ADME Services 麻豆原创: Company Product Type Footprint
3.3.3 In - Vitro ADME Services 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global In - Vitro ADME Services Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global In - Vitro ADME Services 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by End User
5.1 Global In - Vitro ADME Services Consumption Value 麻豆原创 Share by End User (2020-2025)
5.2 Global In - Vitro ADME Services 麻豆原创 Forecast by End User (2026-2031)
6 North America
6.1 North America In - Vitro ADME Services Consumption Value by Type (2020-2031)
6.2 North America In - Vitro ADME Services 麻豆原创 Size by End User (2020-2031)
6.3 North America In - Vitro ADME Services 麻豆原创 Size by Country
6.3.1 North America In - Vitro ADME Services Consumption Value by Country (2020-2031)
6.3.2 United States In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe In - Vitro ADME Services Consumption Value by Type (2020-2031)
7.2 Europe In - Vitro ADME Services Consumption Value by End User (2020-2031)
7.3 Europe In - Vitro ADME Services 麻豆原创 Size by Country
7.3.1 Europe In - Vitro ADME Services Consumption Value by Country (2020-2031)
7.3.2 Germany In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific In - Vitro ADME Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific In - Vitro ADME Services Consumption Value by End User (2020-2031)
8.3 Asia-Pacific In - Vitro ADME Services 麻豆原创 Size by Region
8.3.1 Asia-Pacific In - Vitro ADME Services Consumption Value by Region (2020-2031)
8.3.2 China In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America In - Vitro ADME Services Consumption Value by Type (2020-2031)
9.2 South America In - Vitro ADME Services Consumption Value by End User (2020-2031)
9.3 South America In - Vitro ADME Services 麻豆原创 Size by Country
9.3.1 South America In - Vitro ADME Services Consumption Value by Country (2020-2031)
9.3.2 Brazil In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa In - Vitro ADME Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa In - Vitro ADME Services Consumption Value by End User (2020-2031)
10.3 Middle East & Africa In - Vitro ADME Services 麻豆原创 Size by Country
10.3.1 Middle East & Africa In - Vitro ADME Services Consumption Value by Country (2020-2031)
10.3.2 Turkey In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE In - Vitro ADME Services 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 In - Vitro ADME Services 麻豆原创 Drivers
11.2 In - Vitro ADME Services 麻豆原创 Restraints
11.3 In - Vitro ADME Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 In - Vitro ADME Services Industry Chain
12.2 In - Vitro ADME Services Upstream Analysis
12.3 In - Vitro ADME Services Midstream Analysis
12.4 In - Vitro ADME Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
听
听
*If Applicable.
